Compare, Analyse Sterling Biotech with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ACTAVIS (US) - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ACTAVIS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ACTAVIS
Dec-18
STERLING BIOTECH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1114,280-   
Low Rs39,579-   
Sales per share (Unadj.) Rs26.83,502.9-  
Earnings per share (Unadj.) Rs-15.0-1,128.3-  
Cash flow per share (Unadj.) Rs-5.5369.1-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.914,448.0-  
Shares outstanding (eoy) m267.87332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.6%   
Avg P/E ratio x-0.5-10.6 4.4%  
P/CF ratio (eoy) x-1.332.3 -3.9%  
Price / Book Value ratio x0.10.8 15.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8623,967,842 0.0%   
No. of employees `0001.416.9 8.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.368,939.7 7.7%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.0-22,205.5 13.3%   
INCOME DATA
Net Sales Rs m7,1811,165,081 0.6%  
Other income Rs m4322,280 0.2%   
Total revenues Rs m7,2231,187,361 0.6%   
Gross profit Rs m94730,531 3.1%  
Depreciation Rs m2,543498,047 0.5%   
Interest Rs m4,37767,232 6.5%   
Profit before tax Rs m-5,931-512,467 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,700 0.0%   
Tax Rs m-1,924-6,494 29.6%   
Profit after tax Rs m-4,007-375,273 1.1%  
Gross profit margin %13.22.6 503.2%  
Effective tax rate %32.41.3 2,560.3%   
Net profit margin %-55.8-32.2 173.2%  
BALANCE SHEET DATA
Current assets Rs m14,335477,855 3.0%   
Current liabilities Rs m49,809422,726 11.8%   
Net working cap to sales %-494.04.7 -10,440.6%  
Current ratio x0.31.1 25.5%  
Inventory Days Days40320 2,059.7%  
Debtors Days Days17166 257.3%  
Net fixed assets Rs m55,432131,881 42.0%   
Share capital Rs m2680-   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7014,805,413 0.3%   
Long term debt Rs m9,4781,692,160 0.6%   
Total assets Rs m73,9887,511,954 1.0%  
Interest coverage x-0.4-6.6 5.4%   
Debt to equity ratio x0.60.4 183.1%  
Sales to assets ratio x0.10.2 62.6%   
Return on assets %0.5-4.1 -12.2%  
Return on equity %-27.3-7.8 349.0%  
Return on capital %-6.4-4.8 132.7%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719416,239 0.4%  
From Investments Rs m-3,148228,669 -1.4%  
From Financial Activity Rs m1,426-714,391 -0.2%  
Net Cashflow Rs m-3-69,136 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.8 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: PFIZER  ABBOTT INDIA  FDC  NATCO PHARMA  SUVEN LIFE SCIENCES  



Today's Market

Sensex Ends 424 Points Higher; Sun Pharma and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider (Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - PFIZER COMPARISON

COMPARE STERLING BIOTECH WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS